No abstract available
MeSH terms
-
Adult
-
Antineoplastic Agents, Hormonal / therapeutic use*
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / metabolism
-
Chemotherapy, Adjuvant
-
Cisplatin / administration & dosage
-
Clinical Trials as Topic
-
Consensus Development Conferences as Topic
-
Disease-Free Survival
-
Estrogen Receptor Modulators / therapeutic use*
-
Female
-
Fluorouracil / administration & dosage
-
Gonadotropin-Releasing Hormone / agonists*
-
Humans
-
Methotrexate / administration & dosage
-
Middle Aged
-
Ovariectomy*
-
Premenopause
-
Survival Analysis
-
Tamoxifen / therapeutic use*
-
Treatment Outcome
Substances
-
Antineoplastic Agents, Hormonal
-
Estrogen Receptor Modulators
-
Tamoxifen
-
Gonadotropin-Releasing Hormone
-
Cisplatin
-
Fluorouracil
-
Methotrexate